Spero Therapeutics Inc.

(SPRO) Trade

By |

Profile

Spero Therapeutics Inc is a US-based clinical-stage biopharmaceutical company. It focuses on identifying, developing and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections. The company's product candidate, SPR994, is designed as a broad-spectrum oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It has developed platform technology known as Potentiator Platform to develop drugs to expand the spectrum and potency of existing antibiotics, including formerly inactive antibiotics, against Gram-negative bacteria. In addition, the company is developing SPR720, an oral antibiotic designed for the treatment of pulmonary non-tuberculous mycobacterial infections. The pipeline products include SPR741, SPR206, and SPR720.

Contact Information

Website: www.sperotherapeutics.com/
Email: IR@sperotherapeutics.com
Main Phone: +1 857 242-1600
Address: 675 Massachusetts Avenue
Address 2: 14th Floor
State: MA
City / Town: Cambridge
Country: USA
Postal Code: 02139

Issuer Information

Exchange: NGS
CEO: Ankit Mahadevia
Employees: 41
NAICS: Pharmaceutical Preparation Manufacturing(325412)


Gathering Data... Please wait

Profile

Spero Therapeutics Inc is a US-based clinical-stage biopharmaceutical company. It focuses on identifying, developing and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections. The company's product candidate, SPR994, is designed as a broad-spectrum oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It has developed platform technology known as Potentiator Platform to develop drugs to expand the spectrum and potency of existing antibiotics, including formerly inactive antibiotics, against Gram-negative bacteria. In addition, the company is developing SPR720, an oral antibiotic designed for the treatment of pulmonary non-tuberculous mycobacterial infections. The pipeline products include SPR741, SPR206, and SPR720.

Contact Information

Website: www.sperotherapeutics.com/
Email: IR@sperotherapeutics.com
Main Phone: +1 857 242-1600
Address: 675 Massachusetts Avenue
Address 2: 14th Floor
State: MA
City / Town: Cambridge
Country: USA
Postal Code: 02139

Issuer Information

Exchange: NGS
CEO: Ankit Mahadevia
Employees: 41
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 11.37 $ -0.03 (-0.26%)
Last Price 11.37 Change $ -0.03 Change % -0.26 Tick N/A
Bid 10.75 Bid Size 300.00 Ask 12.91 Ask Size 500.00
Open 11.46 High 11.78 Low 11.09 Prev Close 11.40
Last Trade Volume 23,573 52 Wk Hi 18.23 52 Wk Low 5.52
Market Cap 199.2 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 17,523,835.00 EPS (TTM) -2.17 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 0
Number of Buys 0 0
Number of Sells 0 0
Net Activity 0 0
Last 10 Buys Shares
Allen S. Greene 1,000
Allen S. Greene 1,000
Jack Fingerhut 1,000
John J. Gorman 1,000
Allen S. Greene 1,000
Last 10 Sell Shares
N/A 0
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 30 30 30 30
Low Target Price Estimate 16 16 16 16
Mean Target Price Estimate 25.4 25.4 25.4 25.4
Standard Deviation 5.46 5.46 5.46 5.46
Date of Most Recent Estimate 05/23/18 05/23/18 05/22/18 05/23/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 5 5 4 4
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.33 1.33 1.4 1.4